A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Recruiting · NCT06603246 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 1 | 2026-09-02 | NCT06603246 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genentech, Inc. | 221 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stanford Center for Excellence in Pulmonary Biology | Palo Alto | United States | 1 |
| TTS Research | Boerne | United States | 4 |
| University of Alabama at Birmingham | Birmingham | United States | 193 |
| University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd | Kansas City | United States | 1 |
| University of North Carolina Clinical Research Center | Chapel Hill | United States | 1 |
| UPMC Montefiore Hospital | Pittsburgh | United States | 1 |